全文获取类型
收费全文 | 2662篇 |
免费 | 151篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 295篇 |
妇产科学 | 45篇 |
基础医学 | 302篇 |
口腔科学 | 143篇 |
临床医学 | 157篇 |
内科学 | 508篇 |
皮肤病学 | 79篇 |
神经病学 | 192篇 |
特种医学 | 60篇 |
外国民族医学 | 2篇 |
外科学 | 306篇 |
综合类 | 101篇 |
一般理论 | 1篇 |
预防医学 | 169篇 |
眼科学 | 58篇 |
药学 | 192篇 |
1篇 | |
中国医学 | 16篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 14篇 |
2022年 | 39篇 |
2021年 | 79篇 |
2020年 | 42篇 |
2019年 | 60篇 |
2018年 | 96篇 |
2017年 | 70篇 |
2016年 | 86篇 |
2015年 | 80篇 |
2014年 | 116篇 |
2013年 | 145篇 |
2012年 | 202篇 |
2011年 | 184篇 |
2010年 | 117篇 |
2009年 | 100篇 |
2008年 | 143篇 |
2007年 | 147篇 |
2006年 | 128篇 |
2005年 | 95篇 |
2004年 | 106篇 |
2003年 | 73篇 |
2002年 | 65篇 |
2001年 | 43篇 |
2000年 | 57篇 |
1999年 | 48篇 |
1998年 | 14篇 |
1997年 | 16篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 15篇 |
1992年 | 38篇 |
1991年 | 33篇 |
1990年 | 36篇 |
1989年 | 40篇 |
1988年 | 17篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 23篇 |
1984年 | 17篇 |
1983年 | 16篇 |
1982年 | 9篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1974年 | 12篇 |
1973年 | 8篇 |
排序方式: 共有2823条查询结果,搜索用时 15 毫秒
81.
Sharat Damodar Prashantha Bhat Praveen Kumar Rajesh TR Ratan Gupta 《Indian journal of hematology & blood transfusion》2014,30(1):64-67
Acute leukemia, secondary myelodysplasia and paroxysmal nocturnal hemoglobinuria evolving from severe aplastic anemia (AA) following immunosuppressive therapy are well recognized. However, severe AA occurring after complete remission of acute promyelocytic leukemia (APL) has been documented only once in 2009. We report a case of 30-year-old male diagnosed with APL who achieved complete cytogenetic remission with all-trans retinoic acid based induction regimen and developed severe AA few months later during maintenance therapy. 相似文献
82.
Lisa G. Suter MD Shu-Xia Li PhD Jacqueline N. Grady MS Zhenqiu Lin PhD Yongfei Wang MS Kanchana R. Bhat MPH Dima Turkmani DrPH MBA Steven B. Spivack MPH Peter K. Lindenauer MD MSc Angela R. Merrill PhD Elizabeth E. Drye MD SM Harlan M. Krumholz MD SM Susannah M. Bernheim MD MHS 《Journal of general internal medicine》2014,29(10):1333-1340
BACKGROUND
The Centers for Medicare & Medicaid Services publicly reports risk-standardized mortality rates (RSMRs) within 30-days of admission and, in 2013, risk-standardized unplanned readmission rates (RSRRs) within 30-days of discharge for patients hospitalized with acute myocardial infarction (AMI), heart failure (HF), and pneumonia. Current publicly reported data do not focus on variation in national results or annual changes.OBJECTIVE
Describe U.S. hospital performance on AMI, HF, and pneumonia mortality and updated readmission measures to provide perspective on national performance variation.DESIGN
To identify recent changes and variation in national hospital-level mortality and readmission for AMI, HF, and pneumonia, we performed cross-sectional panel analyses of national hospital performance on publicly reported measures.PARTICIPANTS
Fee-for-service Medicare and Veterans Health Administration beneficiaries, 65 years or older, hospitalized with principal discharge diagnoses of AMI, HF, or pneumonia between July 2009 and June 2012. RSMRs/RSRRs were calculated using hierarchical logistic models risk-adjusted for age, sex, comorbidities, and patients’ clustering among hospitals.Results
Median (range) RSMRs for AMI, HF, and pneumonia were 15.1% (9.4–21.0%), 11.3% (6.4–17.9%), and 11.4% (6.5–24.5%), respectively. Median (range) RSRRs for AMI, HF, and pneumonia were 18.2% (14.4–24.3%), 22.9% (17.1–30.7%), and 17.5% (13.6–24.0%), respectively. Median RSMRs declined for AMI (15.5% in 2009–2010, 15.4% in 2010–2011, 14.7% in 2011–2012) and remained similar for HF (11.5% in 2009–2010, 11.9% in 2010–2011, 11.7% in 2011–2012) and pneumonia (11.8% in 2009–2010, 11.9% in 2010–2011, 11.6% in 2011–2012). Median hospital-level RSRRs declined: AMI (18.5% in 2009–2010, 18.5% in 2010–2011, 17.7% in 2011–2012), HF (23.3% in 2009–2010, 23.1% in 2010–2011, 22.5% in 2011–2012), and pneumonia (17.7% in 2009–2010, 17.6% in 2010–2011, 17.3% in 2011–2012).Conclusions
We report the first national unplanned readmission results demonstrating declining rates for all three conditions between 2009–2012. Simultaneously, AMI mortality continued to decline, pneumonia mortality was stable, and HF mortality experienced a small increase. 相似文献83.
84.
85.
Left gastric artery pseudoaneurysm is a rare but important life-threatening complication of chronic pancreatitis. We report a case of a 54-year-old male with chronic pancreatitis who presented with history of severe abdominal pain. Following an initial suspicion of acute pancreatitis, a computed tomography of abdomen was obtained that showed a large left gastric artery pseudoaneurysm (4×4 cm) with circumferential thrombosis. The patient then underwent successful angiographic coiling of the aneurysm, thus preventing a potentially life-threatening hemorrhage. In conclusion, in patients with a history of chronic pancreatitis who present with abdominal pain, a high index of suspicion should be maintained for alternate causes of abdominal pain such as visceral aneurysms involving left gastric artery. Early recognition is critical and consequences of missing these lesions can be catastrophic. 相似文献
86.
2-Phenylindole and Arylsulphonamide: Novel
Scaffolds Bactericidal against Mycobacterium tuberculosis
Maruti Naik Sandeep Ghorpade LalitKumar Jena Gopinath Gorai Ashwini Narayan Supreeth Guptha Sreevalli Sharma Neela Dinesh Parvinder Kaur Radha Nandishaiah Jyothi Bhat Gayathri Balakrishnan Vaishali Humnabadkar Vasanthi Ramachandran Lava Kumar Naviri Pallavi Khadtare Manoranjan Panda Pravin S. Iyer Monalisa Chatterji 《ACS medicinal chemistry letters》2014,5(9):1005-1009
87.
Ajay Kumar Baranwal Deepali K. Bhat Sanjeev Goswami Sanjay Kumar Agarwal Gurvinder Kaur Narinder Mehra 《Scandinavian journal of immunology》2020,92(5):e12923
Antibody-mediated rejections (AMR) in the absence of circulating anti-HLA-DSA have highlighted the role of non-HLA antibodies, particularly those directed against endothelial cells. Of these, MICA (major histocompatibility complex class I chain–related molecule A) antibodies are the most notable and important because of their potential in promoting graft rejections. Limited studies have focused on the impact of MICA donor-specific antibodies (DSA) on graft outcome as compared to those that are not donor-specific (NDSA). We evaluated pre- and post-transplant sera at POD 7, 30, 90, 180 and the time of biopsy from 206 consecutive primary live donor renal transplant recipients for anti-MICA and anti-HLA antibodies using single antigen bead assay on a Luminex platform. Recipients who developed MICA antibodies and their donors were phenotyped for MICA alleles. For the purpose of antibody analysis, patients were categorized into three major groups: biopsy-proven AMR, acute cellular rejection (ACR) and those with no rejection episodes (NRE). During the mean follow-up period of 17.37 ± 6.88 months, 16 of the 206 recipients developed AMR, while ACR was observed in only 13 cases. A quarter (25%) of the AMR cases had anti-MICA antibodies as compared to 7.7% of those experiencing ACR and 6.2% of the NRE group. Allelic typing revealed that all MICA Ab +ve AMR cases were due to the presence of donor-specific antibodies. MICA-DSA even in the absence of HLA-DSA was significantly associated with AMR but not with ACR when compared with the NRE group (P = <.01). 相似文献
88.
Narendra Joshi Sadhana Kannan Nirupama Kotian Shreyas Bhat Mithila Kale Sujata Hake 《Human immunology》2014
In our earlier studies, single nucleotide polymorphisms (SNPs) associated with anti-inflammatory cytokines were found to influence risk for breast cancer in western Indian women. Analysis of Interleukin 6 (IL-6) −174G>C polymorphism in this cohort (patients = 182; controls = 236) suggested a protective role for IL-6 −174C allele associated with the lower expression of the cytokine (OR = 0.54; 95% CI 0.32–0.89, dominant model). Together these observations suggested that in comparison to Caucasians, inflammation associated-cytokine gene polymorphisms may have higher influence on risk for cancer in this population. To examine this possibility we analyzed data assessing influence of Interleukin 6 (IL-6) −174G>C polymorphism on risk for various cancers. Overall, there was a marginally higher risk for rare allele homozygotes compared to wild type homozygotes (OR = 1.07; 95% CI 1.00–1.15). Increased risks for genitourinary cancers and for skin cancer were also indicated. The ethnicity based analysis indicated a protective effect of the minor allele in Ancestral North Indians (OR = 0.73; 95% CI 0.55–0.97). Site by ethnicity analysis once again revealed a significant protection against breast cancer (OR = 0.51; 95% CI = 0.37–0.70; dominant model) but an opposite influence on the risk of genitourinary malignancies (OR = 2.51; 95% CI 1.59–3.96; recessive model) in this population alone. The observations imply that contribution of IL-6 to inflammation or effector immunity may depend on the site of malignancy. Assessment of available data in relation to prognosis in breast cancer patients also revealed trends that are compatible with the observations of the meta-analysis. Thus, IL-6 −174G>C polymorphism clearly represents a potential modulator of risk for malignant disorders with ethnicity and site dependent trends. The results also support the possibility of higher influence of inflammation related cytokine gene polymorphisms on the risk for cancers in Ancestral North Indians. 相似文献
89.
Nisar Ahmad Nisar Mudasir Sultana Naseer Ahmad Baba Parveez Ahmad Para Hina Ashraf Waiz Shakoor Ahmad Bhat Fayaz Ahmed Zargar Irshad Ahmad 《Comparative clinical pathology》2014,23(4):829-834
The present study was designed to evaluate the effects of chlorpyriphos, lead acetate and vitamin C alone and in combinations, on various haematological parameters in Wistar rats. Rats of 150–200 g body weight were divided into eight groups of six animals each and were subjected to various daily oral treatment regimes for 98 days. Group C served as control receiving only corn oil, group CP received chlorpyriphos at 5.5 mg/kg in corn oil and group L received lead acetate at100?ppm in water, whereas animals in group CP + L received a combination of chlorpyriphos at 5.5 mg/kg in corn oil and lead acetate at 100 ppm in water. Group VC received vitamin C at 100 mg/kg in water; group CP + VC received a combination of chlorpyriphos at 5.5 mg/kg and vitamin C at 100 mg/kg; group L + VC received lead acetate at 100 ppm in water and vitamin C at 100 mg/kg and group CP + L + VC received chlorpyriphos at 5.5 mg/kg, lead acetate at 100 ppm in water and vitamin C at 100 mg/kg. Blood samples were collected on days 0, 30, 60 and 98 post exposure and analysed for packed cell volume (PCV), total erythrocyte count (TEC), haemoglobin (Hb), erythrocyte sedimentation rate (ESR), total leucocyte count (TLC) and differential leucocyte count. A significant decrease in TEC, PCV and Hb and a significant increase in ESR values were observed. However, lead acetate caused an increase in TLC while chlorpyriphos resulted in a decrease in TLC. Both of these toxicants potentiated toxicity of each other. The study demonstrated that treatment of chlorpyriphos- and lead-treated rats with vitamin C significantly altered some of the important haematological parameters revealing the protective effect of this vitamin against haematological alterations induced by chlorpyriphos and lead. 相似文献
90.
Uppoor G. Bhat Vladimir Ilievski Terry G. Unterman Keiko Watanabe 《Journal of periodontology》2014,85(11):1629-1636
Background: A close association between periodontitis and diabetes has been demonstrated in human cross‐sectional studies, but an exact relationship between periodontitis and prediabetes has not been established. Previous studies using animal model systems consistently have shown that hyperinsulinemia occurs in animals with periodontitis compared to animals with healthy periodontium (while maintaining normoglycemia). Because bacterial lipopolysaccharide (LPS) plays an important role in the pathogenesis of periodontitis, we hypothesized that LPS may stimulate insulin secretion through a direct effect on β cell function. To test this hypothesis, pancreatic β cell line MIN6 cells were used to determine the effect of Porphyromonas gingivalis (Pg) LPS on insulin secretion. Furthermore, expression of genes altered by Pg LPS in innate immunity and insulin‐signaling pathways was determined. Methods: MIN6 cells were grown in medium with glucose concentration of normoglycemia (5.5 mM). Pg LPS was added to each well at final concentrations of 50, 200, and 500 ng/mL. Insulin secretion was measured using enzyme‐linked immunosorbent assay. Gene expression levels altered by Pg LPS were determined by polymerase chain reaction (PCR) array for mouse innate and adaptive immunity response and mouse insulin‐signaling pathways, and results were confirmed for specific genes of interest by quantitative PCR. Results: Pg LPS stimulated insulin secretion in the normoglycemic condition by ≈1.5‐ to 3.0‐fold depending on the concentration of LPS. Pg LPS treatment altered the expression of several genes involved in innate and adaptive immune response and insulin‐signaling pathway. Pg LPS upregulated the expression of the immune response–related genes cluster of differentiation 8a (Cd8a), Cd14, and intercellular adhesion molecule‐1 (Icam1) by about two‐fold. LPS also increased the expression of two insulin signaling–related genes, glucose‐6‐phosphatase catalytic subunit (G6pc) and insulin‐like 3 (Insl3), by three‐ to four‐fold. Conclusions: We have demonstrated for the first time that Pg LPS stimulates insulin secretion by pancreatic β cell line MIN cells. Pg LPS may have significant implications on the development of β cell compensation and insulin resistance in prediabetes in individuals with periodontitis. 相似文献